Twenty-four isolates of nutritionally variant streptococci, previously categorized as species included among the viridans streptococci, were tested for susceptibility to 12 antimicrobial agents. Minimum inhibitory concentrations for these isolates and for a control group of viridans streptococci with no apparent nutritional deficiencies were determined in two microdilution systems. Pyridoxal hydrochloride, which enhances growth of the nutritional variants, was added to one of these microdilution systems but not to the other. An agar dilution method was also used to test the nutritionally variant isolates. Minimum inhibitory concentrations determined by the three methods compared favorably. Penicillin, nafcillin, methicillin, and clindamycin were less effective in vitro against the nutritional variants than were the other antibiotics tested. Streptomycin, however, was less effective against the control isolates.
A physiological relationship between nutritionally variant streptococci and the viridans group of streptococci has been established. The nutritionally variant streptococci are known to be involved in bacterial endocarditis, as is the viridans group. They may be nondetectable in culture without the addition to media of certain growth supplements, such as sulfhydryl compounds or vitamin B6 analogs, or without the streaking to seeded agar plates of another organism, such as a staphylococcus, around which most nutritionally variant streptococcal isolates will "satellite." Clinical microbiology laboratories should be prepared to detect and identify nutritionally deficient organisms from blood cultures (5) .
Antimicrobial susceptibilities of the viridans streptococci have been investigated extensively (2, 6, 14, 16) . Penicillin remains the antibiotic of choice in the treatment of endocarditis caused by viridans streptococci; the combined use of an aminoglycoside with penicillin, however, is generally necessary, particularly in patients infected with relatively penicillin-resistant organisms. With respect to the nutritionally variant viridans streptococci, antimicrobial susceptibility studies have provided minimal information, primarily because of the paucity of test organisms. Levels of penicillin resistance determined in previous studies are well beyond the reported mean levels ofresistance of other viridans streptococci. Combined antibiotic treatment of patients with endocarditis due to nutritionally variant streptococci again may often be necessary (3, 8) .
The present study was initiated to evaluate the antimicrobial susceptibility patterns of 24 strains of nutritionally variant streptococci. 
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The degree of antimicrobial susceptibility of the 24 nutritionally variant streptococci compared favorably in the three systems evaluated (Tables 1 and 2 ). In Table 1 (17) . By this standard, no more than one-third of the 24 nutritionally variant isolates used in the present study can be regarded as susceptible to penicillin alone. Our results support the previous findings of Carey et al. (3) who found that the penicillin MICs for two nutritionally variant strains of streptococci tested by them were at least 0.78 and 3.13 ,ug/ml, respectively. The same strains were relatively susceptible to streptomycin (MICs = 1.95 and 3.9 ,Ag/ml, respectively). Further evidence of decreased penicillin susceptibility was supplied by McCarthy and Bottone, who tested five nutritionally variant isolates in thioglycolate broth. The penicillin MICs for these strains ranged from 0.6 to 6.0 ,ug/ml (8) .
The synergistic activity of penicillin and streptomycin against enterococci is well documented, and as a result this combination therapy for enterococcal infections is extensively employed by physicians (7, 9, 11) . Unfortunately, the optimum method of treating infections due to viridans streptococci and group D non-enterococci is not quite as well established. However, recent data obtained from patient treatment records, as well as through the use of experimental animal models, indicate that the penicillin-streptomycin combination should be advised for the management of human endocarditis caused by these organisms also unless the use of streptomycin is contraindicated (11, 12, 17) . The resulting synergism obtained from the combined use of these drugs has been shown to produce a considerably faster rate of bactericidal decolonization of vegetating organisms.
In the present study we measured only in vitro inhibitory responses to antimicrobial agents by an infrequently encountered group of viridans streptococci. Nonetheless, the data supply further evidence to support another situation in which the penicillin-plus-streptomycin regimen may be advised.
Because the nutritionally variant organisms used in this study have been previously shown to physiologically resemble other species included in the viridans streptococci, similar antibiograms would be expected. Susceptibility levels to most of the antimicrobial agents were similar for the nutritional variants and for the 
